Skip to content

Clinical trials

Phase 3 Psychotic Disorders trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 3 Country / region: Israel Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20051
20062
20081
20112
20172
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Not yet recruiting2
Recruiting2
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alkermes, Inc.2
Beersheva Mental Health Center2
Eli Lilly and Company2
Sheba Medical Center2
University of Oxford2
European Group for Research In Schizophrenia1
Janssen-Cilag International NV1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Sha'ar Menashe Mental Health Center1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders16
Schizophrenia11
Alzheimer Disease1
Cognitive Dysfunction1
Mania1
Teratogenesis1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.